Mediterranean Fish Vaccine Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Mediterranean Fish Vaccine Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Mediterranean Fish Vaccine Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Increasing disease outbreaks in aquaculture
5.1.3 Rising global demand for seafood
5.1.4 Strict regulations on antibiotic usage
5.1.5 Advancements in vaccine technology
5.1.6 Growing aquaculture industry
5.1.7 Government initiatives to promote sustainable aquaculture

5.2 Market Opportunities

5.2.1
5.2.2 Emerging markets in Asia-Pacific
5.2.3 Increasing adoption of aquaculture practices
5.2.4 Rising consumer awareness about food safety
5.2.5 Growing demand for disease-resistant fish
5.2.6 Development of novel vaccine delivery systems
5.2.7 Collaboration between pharmaceutical companies and aquaculture farms

5.3 Future Trends

5.3.1
5.3.2 Personalized vaccines
5.3.3 AI-driven vaccine development
5.3.4 Probiotics and prebiotics as adjuvants
5.3.5 Nanotechnology-based vaccine delivery
5.3.6 Integrated disease management strategies
5.3.7 Eco-friendly and sustainable vaccine production

5.4 Impact of Drivers and Restraints

6. Mediterranean Fish Vaccine Market Regional Analysis

6.1 Mediterranean Fish Vaccine Market Overview

6.2 Mediterranean Fish Vaccine Market Revenue 2020-2030 (US$ Million)

6.3 Mediterranean Fish Vaccine Market Forecast Analysis

7. Mediterranean Fish Vaccine Market Analysis – by Vaccine Type

7.1 Inactivated Vaccine

7.1.1 Overview
7.1.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Live-attenuated Vaccine

7.2.1 Overview
7.2.2 Live-attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Toxoid Vaccine

7.3.1 Overview
7.3.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Subunit Vaccine

7.4.1 Overview
7.4.2 Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Conjugate Vaccine

7.5.1 Overview
7.5.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Recombinant Vector Vaccine

7.6.1 Overview
7.6.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

8. Mediterranean Fish Vaccine Market Analysis – by Route of Administration

8.1 Immersion Vaccine

8.1.1 Overview
8.1.2 Immersion Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Injection Vaccine

8.2.1 Overview
8.2.2 Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Oral Vaccine

8.3.1 Overview
8.3.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9. Mediterranean Fish Vaccine Market Analysis – by Species

9.1 Turbot

9.1.1 Overview
9.1.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.2 European Anchovy and Seabass

9.2.1 Overview
9.2.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Salmon

9.3.1 Overview
9.3.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Mediterranean Sea Bass

9.4.1 Overview
9.4.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Common Dentex and Common Pandora

9.5.1 Overview
9.5.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.6 Sea Bream

9.6.1 Overview
9.6.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.7 Rainbow Wrasse

9.7.1 Overview
9.7.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.8 Sparus Aurata

9.8.1 Overview
9.8.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.9 Trout

9.9.1 Overview
9.9.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.10 Mediterranean Swordfish and Bluefin Tuna

9.10.1 Overview
9.10.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

9.11 Grouper and Amberjack

9.11.1 Overview
9.11.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

10. Mediterranean Fish Vaccine Market – Mediterranean Analysis

10.1 Mediterranean

10.1.1 Mediterranean Fish Vaccine Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Mediterranean Fish Vaccine Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Mediterranean: Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Vaccine Type
10.1.1.1.2 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Route of Administration
10.1.1.1.3 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Species

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Mediterranean Fish Vaccine Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Zoetis Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Merck & Co Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 HIPRA SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 ICTYODEV SAS

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Acuipharma Aquaculture Health SL

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Phibro Animal Health Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Vaxxinova International BV

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Kyoto Biken Laboratories Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Elanco Animal Health Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Ceva SA

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights